Alignment Healthcare CEO John Kao Sells $21.4M in ALHC Stock — Five Insiders Unload $31.5M

Alex Rivera

Alignment Healthcare CEO John Kao sold $21.4M in ALHC across 5 transactions, with $87.5M in career sales. President Maroney added $7.9M. Five total insiders sold $31.5M.

Alignment Healthcare CEO John E. Kao sold $21.4 million in ALHC stock across 5 transactions, bringing his career insider sales to $87.5 million. President Dawn Maroney added $7.89 million, and three other insiders contributed to a total of $31.51 million in insider selling.

Five Insiders, $31.5M

Insider Title Transactions Value Shares After Career Sales
John E. Kao Chief Executive Officer 5 $21.40M 2,234,294 $87.5M
Dawn Maroney President 4 $7.89M 1,385,167 $34.3M
Robert Scavo Chief Information Officer 2 $1.30M 503,014 $4.5M
Christopher Joyce Chief Legal & Admin Officer 3 $0.68M 307,699 $6.3M
Hyong Kim Chief Medical Officer 2 $0.24M 349,639 $5.0M
Total: 5 insiders, 16 transactions $31.51M

CEO Kao: $87.5M Career Seller

John Kao founded Alignment Healthcare to transform senior care through a technology-driven model. His $87.5 million in career insider sales from the Medicare Advantage-focused company reflects years of systematic equity monetization. He retains 2.23 million shares — a substantial position — but his career sales are roughly 4x the value of his remaining holdings.

President Maroney: $34.3M Career

Dawn Maroney, who runs the company's day-to-day operations, has sold $34.3M in career ALHC stock. Her $7.89M sale in this round was her largest yet. She retains 1.39 million shares, maintaining meaningful alignment, though her selling pace has accelerated.

Healthcare Tech at a Crossroads

Alignment Healthcare operates a tech-enabled platform serving Medicare Advantage patients. The company is in the middle of scaling its model across new markets while pursuing profitability. For the CEO and President to sell $29.3M combined at current levels suggests they view the current valuation as an appropriate level to take profits — regardless of the growth story.

  • CEO sold 68% of total: $21.4M of $31.5M — dominant seller
  • 5 insiders selling: CEO, President, CIO, CLO, and CMO
  • Combined career: $137.6M from these five executives
  • CEO's career at $87.5M: Largest single-person total at the company

For ALHC investors, the concentrated selling from the CEO and President warrants attention. When the two people most responsible for Alignment Healthcare's growth strategy sell a combined $29.3M, it's the clearest available signal about their personal assessment of the risk-reward at current prices.

Explore all research